Fredrik Dahl
Patrimonio netto: 444 692 $ in data 31/05/2026
Patrimonio netto: 444 692 $ in data 31/05/2026
Fredrik Dahl is the founder of Colibri Ventures AB,Pixelgen Technologies AB. Currently, Dr. Dahl is Chairman at Faboss Invest AB, Director at Devyser Diagnostics AB starting 2025, Director at Nucleus Capital AB, and Director at Llya Pharma AB. Formerly, Dr. Dahl was Director at Moligo Technologies AB, Chief Technology Officer at Halo Genomics AB, and Chief Technology Officer at Vanadis Diagnostics AB. Education includes undergraduate and doctorate degrees from the University of Uppsala.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 07/05/2025 | 44.150 ( 0,27% ) | 444 692 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| DEVYSER DIAGNOSTICS AB | Direttore/Membro del Consiglio | 01/01/2021 |
Colibri Ventures AB | Fondatore | - |
Faboss Invest AB | Presidente | - |
Nucleus Capital AB | Direttore/Membro del Consiglio | - |
Pixelgen Technologies AB
Pixelgen Technologies AB Packaged SoftwareTechnology Services Develops bio-analytical tools for immune cell surface protein | Fondatore | - |
Llya Pharma AB | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Vanadis Diagnostics AB
Vanadis Diagnostics AB Miscellaneous Commercial ServicesCommercial Services Develops novel solution for non-invasive prenatal testing | Direttore Tecnico/Scientifico/R&S | - |
Halo Genomics AB
Halo Genomics AB Medical/Nursing ServicesHealth Services Develops products for preparation of DNA for the next generation sequencing platforms | Direttore Tecnico/Scientifico/R&S | - |
Moligo Technologies AB
Moligo Technologies AB BiotechnologyHealth Technology Engages in producing ultrapure DNA | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Halo Genomics AB
Halo Genomics AB Medical/Nursing ServicesHealth Services Develops products for preparation of DNA for the next generation sequencing platforms | Health Services |
Devyser Diagnostics AB
Devyser Diagnostics AB Medical SpecialtiesHealth Technology Manufactures and sells diagnostic kits | Health Technology |
Vanadis Diagnostics AB
Vanadis Diagnostics AB Miscellaneous Commercial ServicesCommercial Services Develops novel solution for non-invasive prenatal testing | Commercial Services |
Colibri Ventures AB | |
Faboss Invest AB | |
Moligo Technologies AB
Moligo Technologies AB BiotechnologyHealth Technology Engages in producing ultrapure DNA | Health Technology |
Pixelgen Technologies AB
Pixelgen Technologies AB Packaged SoftwareTechnology Services Develops bio-analytical tools for immune cell surface protein | Technology Services |
Nucleus Capital AB | |
Llya Pharma AB |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale